EXJADE, also known by its generic name deferasirox, is an oral medication primarily used for the treatment of chronic iron overload due to frequent blood transfusions. Patients with conditions such as beta-thalassemia, sickle cell disease, or myelodysplastic syndromes often require regular blood transfusions, which can lead to an excess accumulation of iron in the body. Excessive iron can be harmful, potentially damaging vital organs like the heart and liver. EXJADE works by binding to excess iron in the bloodstream, allowing it to be excreted from the body through the feces. This medication is available in tablet form and is usually taken once daily on an empty stomach. As with any medication, it is important for patients to follow their healthcare provider's instructions and be aware of potential side effects, which can include kidney and liver function changes, gastrointestinal symptoms, and skin rash.